Author Correction: Addressing proteolytic efficiency in enzymatic degradation therapy for celiac disease

Correction to: Scientific Reports https://doi.org/10.1038/srep30980, published online 02 August 2016

This Article contains an error in Figure 6 where the bottom two images are vertical mirror images of each other.

Figure 6.

Nepenthes fluid protease treatment of gliadin prevents gliadin-induced inflammation in the NOD/DQ8 transgenic mouse model of gluten-sensitivity. Intraepithelial lymphocyte (IEL) counts quantitated by immunostaining of proximal small intestine villi tips, in sensitized mice challenged with pepsin-treated gliadin (positive control), vehicle alone (negative control, gliadin-free diet), fluid protease-treated gliadin (1:264 ratio) and recombinant nepenthesin-II treated gliadin (1:100 ratio). Representative immunostained sections of intestinal tissues shown to the right at 40× magnification. Statistical significance (n = 8 for each state, *p < 0.05, ***p < 0.001).

The correct Figure 6 and accompanying legend appear below.

This change does not affect the conclusions of the Article.